Syncona Portfolio Ltd

Holdings History for Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (AUTL)

Symbol: AUTL on Nasdaq
Investment type: Equity / American Depositary Shares, each representing one ordinary share, par value $0.000042 per share
Latest Disclosed Shares Owned: 28,821,053 shares
Security Ownership %: 11%

Shares, Excluding Options vs Price

Value, Excluding Options

Syncona Portfolio Limited ownership in Autolus Therapeutics plc American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (AUTL)

07 May 2025 - Syncona Portfolio Limited has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 28,821,053 shares of Autolus Therapeutics plc American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (AUTL). This represents 11% ownership of the company. This is the first filing by Syncona Portfolio Ltd disclosing ownership of Autolus Therapeutics plc American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (AUTL).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Syncona Portfolio Limited	11%		$37,755,579	28,821,053			$1.31	13G/A	31 Mar 2025	07 May 2025, 09:00

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	96%	0%	$33,115,033	16,640,720	0		$1.99	Q4 2025
30 Sep 2025	98%	0%	$27,124,374	16,640,720	0		$1.63	Q3 2025
30 Jun 2025	98%	0%	$37,940,842	16,640,720	0		$2.28	Q2 2025
31 Mar 2025	98%	0%	$25,793,116	16,640,720	0		$1.55	Q1 2025
31 Dec 2024	74%	-8.5%	$39,105,692	16,640,720	-1,913,904	-10%	$2.35	Q4 2024
30 Sep 2024	83%	-13%	$67,353,285	18,554,624	-2,792,205	-13%	$3.63	Q3 2024
30 Jun 2024	87%	0%	$74,286,965	21,346,829	0		$3.48	Q2 2024
31 Mar 2024	91%	0%	$136,192,769	21,346,829	0		$6.38	Q1 2024
31 Dec 2023	87%	0%	$137,473,579	21,346,829	0		$6.44	Q4 2023
30 Sep 2023	74%	0%	$49,738,112	21,346,829	0		$2.33	Q3 2023
30 Jun 2023	77%	0%	$50,805,453	21,346,829	0		$2.38	Q2 2023
31 Mar 2023	64%	0%	$39,278,165	21,346,829	0		$1.84	Q1 2023
31 Dec 2022	64%	+42%	$40,558,975	21,346,829	+14,000,000	+191%	$1.90	Q4 2022
30 Sep 2022	27%	0%	$15,723,000	7,346,829	0		$2.14	Q3 2022
30 Jun 2022	30%	0%	$20,792,000	7,346,829	0		$2.83	Q2 2022
31 Mar 2022		0%	$38,130,000	7,346,829	0		$5.19 ^*	Q1 2022
31 Dec 2021	36%	0%	$38,130,000	7,346,829	0		$5.19	Q4 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.